What Do We Know about the Serotonergic Genetic Heterogeneity in Attention-Deficit/Hyperactivity and Autistic Disorders?

Publisher： Karger

E-ISSN： 1423-033x|40|5|329-337

ISSN： 0254-4962

Source： Psychopathology, Vol.40, Iss.5, 2007-07, pp. : 329-337

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Attention Deficit Hyperactivity Disorder Symptoms in Pervasive Developmental Disorders: Association with Autistic Behavior Domains and Coexisting Psychopathology

By  

Psychopathology, Vol. 40, Iss. 3, 2007-02 ,pp. : 172-177

Karger

Access to resources Recommend Favorite

Is it time for a new classification of mast cells? What do we know about mast cell heterogeneity?

By  

IMMUNOLOGICAL REVIEWS (ELECTRONIC), Vol. 282, Iss. 1, 2018-03 ,pp. : 35-46

John Wiley & Sons Inc

Access to resources Recommend Favorite

What do we actually know about the referral process?

By Perkins Peter  

British Journal of General Practice, Vol. 62, Iss. 595, 2012-02 ,pp. : 70-70

Royal College of General Practitioners

Access to resources Recommend Favorite

What do we know about the safety of corticosteroids in rheumatoid arthritis?

By Ethgen Olivier   de Lemos Esteves Frédéric   Bruyere Olivier   Reginster Jean-Yves  

Current Medical Research and Opinion, Vol. 29, Iss. 9, 2013-09 ,pp. : 1147-1160

Informa Healthcare

Access to resources Recommend Favorite

What Do We Know About Medication Errors in Inpatient Psychiatry?

By Grasso Benjamin C.   Rothschild Jeffrey M.   Genest Robert   Bates David W.  

Joint Commission Journal on Quality and Patient Safety, Vol. 29, Iss. 8, 2003-08 ,pp. : 391-400

Joint Commission Resources

Access to resources Recommend Favorite